Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03577327 · ClinicalTrials.gov registry record

The Gut and Skin Microbiome in Vitiligo Disease Progression

A clinical trial of Healthy and Vitiligo, sponsored by Northwestern University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT03577327 is a study of Healthy and Vitiligo that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 100 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03577327, a study of Healthy and Vitiligo, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Conditions Studied

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-05-30
Est. Completion 2025-12

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03577327

The ClinicalTrials.gov registry entry for NCT03577327 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT03577327 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03577327 about?

NCT03577327 is a clinical study titled "The Gut and Skin Microbiome in Vitiligo Disease Progression". Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of ...

What is the current status of trial NCT03577327?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2019-05-30. Estimated completion is 2025-12.

What conditions does trial NCT03577327 study?

This clinical trial studies the following conditions: Healthy, Vitiligo.

Who is sponsoring clinical trial NCT03577327?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03577327 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.